Fig 4. Driver mutations detected by tissue-based analysis, ctDNA analysis, or both.

EGFR exon 19 deletions, EGFR L858R mutations and KRAS G12/G13 mutations detected in tissue, blood, or both in patients for whom both tissue- and ctDNA analyses were available. The numbers of detected mutations are shown per stage of disease.